Clinical trial
Systematic Evaluation of Endothelial Dysfunction as a Prognostic Marker for Outcomes in Women With Preeclampsia
NCT06912477 is registered in ClinicalTrials.gov with Heidelberg University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Systematic Evaluation of Endothelial Dysfunction as a Prognostic Marker for Outcomes in Women With Preeclampsia
- Lead sponsor
- Heidelberg University
- Phase
- Observational
- Overall status
- Recruiting
- Start date
- May 8, 2025
- Completion date
- July 31, 2027
- Enrollment
- 385 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
hypertensive disorder of pregnancy, preeclampsia (pe)